HealthCare Global Enterprises (HCG) has launched patient treatments using Karnataka's first Elekta Unity MR-Linac, introducing MR-guided adaptive radiation therapy to enhance precision and patient outcomes.
- Introduction of Karnataka's first Elekta Unity MR-Linac at HCG.
- Integration of 1.5 Tesla MRI with a linear accelerator for real-time tumor visualization.
- Ability to adapt radiation plans online based on daily anatomical changes.
- Addressing the projected 57.5% rise in Indian cancer cases by 2040.
HealthCare Global Enterprises (HCG) in Bengaluru has achieved a significant clinical milestone by initiating patient treatments with the state's first Elekta Unity MR-Linac. This advancement brings MR-guided adaptive radiation therapy (MRgRT) to Karnataka and neighboring regions, offering a level of precision previously unavailable in the region.
The Unity system is a technological marvel that combines a high-field 1.5 Tesla MRI scanner with a linear accelerator. This allows oncologists to visualize the tumor and surrounding healthy anatomy in real-time during the actual delivery of radiation. By adapting the treatment plan 'online' to account for anatomical shifts between sessions, the care team can maximize the dose to the tumor while sparing critical healthy tissues.
Why This Matters
BozokMedia analysis shows that as cancer rates surge in India—with GLOBOCAN estimating 2.08 million new cases by 2040—the demand for personalized oncology is critical. The shift from static planning to adaptive therapy means fewer side effects and higher cure rates. HCG's adoption of this technology positions the institution as a leader in the 'precision medicine' movement, reducing the need for patients to travel abroad for advanced care.
"With this adaptive therapy, patients will benefit from radiation focused directly on the tumor, with minimal or no exposure to surrounding healthy tissue." - Dr. B.S. Ajaikumar, Founder and Chairman, HCG.
The clinical efficacy of the system was recently demonstrated in the case of a 74-year-old male with high-risk localized prostate cancer. Using hypofractionated radiotherapy, the team accounted for prostate movement in real-time, allowing the patient to complete a five-week course with excellent tolerance and minimal organ exposure.
| Feature | Conventional Radiation | MR-Guided Adaptive Therapy |
|---|---|---|
| Imaging Timing | Pre-treatment (Static) | During treatment (Live) |
| Precision | Standard | Ultra-High (Adaptive) |
| Tissue Sparing | Moderate | Maximum |
Frequently Asked Questions
1. What makes the Elekta Unity MR-Linac different from standard LINACs?
The primary difference is the integrated MRI, which allows for real-time visualization and immediate adjustment of the radiation beam based on the patient's anatomy that day.
2. Who benefits most from this technology?
Patients with tumors located near critical organs or those whose tumors move (like prostate or liver cancer) benefit most from this adaptive approach.
